Himalaya Therapeutics Announces Appointment of Nicholas Desjardins as Chief Fiscal Officer
TipRanks 3 “Strong Buy” Dividend Stocks Yielding Close to 7% These past 12 months have
Himalaya
Himalaya Therapeutics Announces Appointment of Nicholas Desjardins as Chief Fiscal Officer
SAN DIEGO, April 19, 2021 /PRNewswire/ — Himalaya Therapeutics (“Himalaya”), a clinical-stage biopharmaceutical company targeted on